Subcutaneous Partnerships Are Stepping Stones: Halozyme Touts Its Insulin Product
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite multiple partnerships around a technology platform that can ease administration of existing drugs, Halozyme says its future prospects revolve more around a significant opportunity in insulin-pump products.